Michael R. Minogue, Chairman, President, CEO at ABIOMED INC (ABMD), sold 205,700 shares at $434.47 ($90.4M) on 2018-06-21, disclosed to the SEC on 2018-06-25.
Open-market sale of $90.4M ABMD by Chairman, President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $434.47 | 2,400 | $1.0M | 1.2% |
| 2 | $434.47 | 2,400 | $1.0M | 1.2% |
| 3 | $435.63 | 7,984 | $3.5M | 3.8% |
| 4 | $435.63 | 7,984 | $3.5M | 3.8% |
| 5 | $436.76 | 5,481 | $2.4M | 2.6% |
| 6 | $436.76 | 5,481 |
| $2.4M |
| 2.6% |
| 7 | $437.88 | 8,009 | $3.5M | 3.9% |
| 8 | $437.88 | 8,009 | $3.5M | 3.9% |
| 9 | $438.65 | 30,611 | $13.4M | 14.9% |
| 10 | $438.65 | 30,611 | $13.4M | 14.9% |
| 11 | $439.74 | 24,497 | $10.8M | 11.9% |
| 12 | $439.74 | 24,497 | $10.8M | 11.9% |
| 13 | $440.60 | 6,696 | $3.0M | 3.3% |
| 14 | $440.60 | 6,696 | $3.0M | 3.3% |
| 15 | $441.75 | 3,634 | $1.6M | 1.8% |
| 16 | $441.75 | 3,634 | $1.6M | 1.8% |
| 17 | $442.75 | 1,293 | $572K | 0.6% |
| 18 | $442.75 | 1,293 | $572K | 0.6% |
| 19 | $443.77 | 3,300 | $1.5M | 1.6% |
| 20 | $445.17 | 4,325 | $1.9M | 2.1% |
| 21 | $445.17 | 4,325 | $1.9M | 2.1% |
| 22 | $445.92 | 1,605 | $716K | 0.8% |
| 23 | $445.92 | 1,605 | $716K | 0.8% |
| 24 | $447.01 | 4,165 | $1.9M | 2.1% |
| 25 | $447.01 | 4,165 | $1.9M | 2.1% |
| 26 | $450.06 | 1,000 | $450K | 0.5% |
| Total | $439.57 avg | 205,700 | $90.4M | 100% |
| Filing → |
| ABMD | SELL | 2021-08-25 | $1.2M | — | Filing → |
| ABMD | SELL | 2021-08-10 | $11.0M | — | Filing → |
| ABMD | SELL | 2021-08-06 | $15.9M | — | Filing → |